SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001607062-15-000445
Filing Date
2015-10-09
Accepted
2015-10-09 16:01:42
Documents
13
Period of Report
2015-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K gnbt73115form10k.htm 10-K 1251706
2 EXHIBIT 3 ex3.htm EX-3 8405
3 EXHIBIT 21 ex21.htm EX-21 7038
4 EXHIBIT 23.1 ex23_1.htm EX-23.1 3539
5 EXHIBIT 31.1 ex31_1.htm EX-31.1 14468
6 EXHIBIT 31.2 ex31_2.htm EX-31.2 14318
7 EXHIBIT 32 ex32.htm EX-32 5701
  Complete submission text file 0001607062-15-000445.txt   4793980

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE gnbt-20150731.xml EX-101.INS 636638
9 XBRL SCHEMA FILE gnbt-20150731.xsd EX-101.SCH 59464
10 XBRL CALCULATION FILE gnbt-20150731_cal.xml EX-101.CAL 50624
11 XBRL DEFINITION FILE gnbt-20150731_def.xml EX-101.DEF 177518
12 XBRL LABEL FILE gnbt-20150731_lab.xml EX-101.LAB 386686
13 XBRL PRESENTATION FILE gnbt-20150731_pre.xml EX-101.PRE 287363
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 000-25169 | Film No.: 151153173
SIC: 2834 Pharmaceutical Preparations